In this study we have isolated and identified a progenitor cell population located in murine pancreatic tissue. This cell population has specific properties that make it different from previously described candidate pancreatic progenytor cell populations. It is located in the periductal region outside the islet architecture yet the cells have features consistent with endodermal development and endocrine functions within the islet. Cells are proliferative and capable of differentiation into pancreatic lineages expressing pancreatic associated transcription factors and proteins and maintaining the ability to produce insulin.
INTRODUCTION
Diabetes has reached epidemic proportions in the U.S. with an estimated prevalence of 6.3% of the U.S. population (translating into more than 18 million people) currently diagnosed with the disease [1] . Diabetes affected an estimated 171 million people worldwide in 2000, and this number is predicted to rise to 366 million by 2030, owing to increases in age, obesity, and urbanization of the world's population [2] . This rising incidence of patients diagnosed with diabetes drives the qu est for the development of novel therapies.
Diabetes is unique in that there is already a preexisting protocol of transplantation of donor beta cells to diabetic recipients which ameliorates the disease. However, the requirement of large numbers of beta cells and a shortage of donor tissue limits the procedure to select cases. The need for a highly proliferative and easily accessible cell population that can replace transplanted islets has led to the search for stem cell populations that can be used to treat the disease. Numerous investigators have attempted to identify and isolate a pancreatic stem or progenitor cell using distinct markers [3] [4] [5] [6] [7] . While a great deal of information is known about pancreatic development from the embryonic period through adulthood, there have been tremendous challenges associated with characterizing a putative pancreatic or islet stem cell. While the presence of precursor cells has been debated over the past decade [8] [9] [10] , the potential presence of a precursor cell remains a possibility, as demonstrated by Liu et al via cell tracing experiments [11] . One group has established a murine pancreatic stem cell line that expresses PDX-1 but does not express select transcription factors such as Ngn3, BETA2/NeuroD, Pax4, Pax6, Isl-1, Nkx2.2 or Nkx6.1 [12] . Populations in mouse and human have been derived from pancreatic ductal cell components and maintained in long-term culture, where they could differentiate into multi-lineage cell types [13] [14] [15] . More recent experiments have mechanistically demonstrated how pancreatic-duct cells can serve as a source of regeneration [16] . The challenge with many of these populations was that they were characterized retrospectively after isolation. Petropavlovskaia et al. characterized a "small cell" isolated from islets that demonstrates expression of several pancreatic markers (insulin, glucagon, somatostatin, pancreatic polypeptide, etc.) during culture but doesn't express some of the stem cell related markers (e.g. c-kit, CD34) [17] . Additionally the identified cells demonstrate a very low level of proliferation.
Other researchers have studied embryonic stem cells to explore if they could be driven towards a pancreatic phenotype [18, 19] . Some researchers have induced embryonic stem cells to a pancreatic precursor cell based on the cell's expression of Insulin I, Insulin II, PDX1 and other early marker proteins such as peptide YY (PYY) and glucagon [20, 21] . Some investigators have focused on the expression of Ngn3 as a marker for a pancreatic progenitor cell during embryogenesis [22] . Select studies have provided direct evidence that Ngn3+ cells are potential islet progenitors during embryogenesis as well as in adult mice, and that Pdx1 + cells give rise to all three types of pancreatic tissue: exocrine, endocrine and ductal [22] . Ngn3 is required for specification of pancreatic endocrine cells along with additional molecules, such as Notch family members [23, 24] . Ngn3+ cells are unipotent at the single-cell level but together as a population they are multipotent [25] . Other researchers have focused on fetal pancreatic duct cells as the origin of a multipotential cell population capable of differentiating into insulin-producing cells [26] . In addition there have been studies looking at clonal identification of multipotent precursors from adult mouse pancreas [27, 28] . Under further selection, these cells have produced distinct populations of pancreatic β-, α-and δ-cells, pancreatic exocrine and stellate cells, and neuronal and glial cells [27, 28] . Additional investigators have looked at non-β-cell populations (e.g. α-cells, gland cells, etc.) as a source of potential beta cells [29, 30] .
We have identified a pancreatic progenitor cell isolated from mouse pancreas. This highly proliferative cell population is purified based on expression of stem cell antigen 1 (Sca-1). Cells express many transcription factors associated with pancreatic development and also have the ability to produce proteins associated with pancreatic endocrine function. These cells also that the ability to secret a basal amount of insulin.
MATERIALS AND METHODS

Reagents
Chemicals were obtained from the Sigma Chemical Company (St. Louis, MO) unless otherwise stated. Sca-1 antibody was purchased from BD Biosciences (San Jose, CA).
Mice
C57BL/6 mice breeding pairs were purchased from the Jackson Laboratory (Bar Harbor, ME). All animals were maintained on a rodent chow under a constant day/night cycle. 2 -3 week old mice were used in all experiments. All care and use of animals was approved by the Institutional Animal Care and Use Committee at the University of North Carolina at Chapel Hill in accordance with the principles and procedures outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Enrichment, Cell Sorting, and Culture
Pancreatic tissue from 2 week old C57Bl/6 mice was removed and the tissue was digested with Liberase Blendzyme 3 (Roche) in a 36˚ water bath for 15 min with agitation every 5 minutes. The tissue was then sheared with a 22G needle and tweezers and pipetted until all cells were disassociated. Cell sorting was performed using magnetic activated cell sorting (MACS ® , Miltenyi, Biotec, Inc.). The cells were separated using a Sca-1 antibody conjugated to mini-magnetic beads (Miltenyi Biotec Inc.; Auburn, CA, (http://www.milten yibiotec.com) according to the manufacturer's instructions. Sca1 + cells were eluted with a purity of >94% by flow cytometry and >80% viability. Standard culture conditions involved plating the cells on tissue culture dishes coated with Fibronectin and Concanavalin A in 2 ml of DMEM (Dulbecco's Modified Eagle's medium) and 10% FBS suPplemented with 10 ng/ml BMP-4 (R & D Systems), 1400 U/ml ESGRO(Millipore, Temecula, CA), and B27 supplement (Invitrogen, Carlsbad, CA). Cellular density was 1 × 10 6 cells per 35 mm well. The cells were cultured in a 5% CO 2 /95% room air incubator at 37˚C. The cells were passaged when they achieved >75% confluence on the tissue culture dishes.
Microscopy
The cells in culture were visualized with either a Zeiss Axiovert 100 inverted fluorescent microscope and images were captured with Zeiss Axiovision 3.1 software or an Olympus BX61 Upright Fluorescence with Improvision's Velocity software provided by the Microscopy Services lab in the department o Molecular and Cellular Pathology.
Fluorescent Immunophenotyping and Flow Cytometry
Cells were stained for immunofluorescense using antibodies directly labeled with the relevant fluoroprobe. Cells were considered positive when fluorescence was greater than 95% of the negative control cells. Isotype control antibodies were used as negative controls. Cells were suspended in room temperature PBS containing 2% FBS at 1 × 10 6 cells per ml. Antibodies were primary conjugates against Sca-1 (BD Biosciences; San Jose, CA). Cells were incubated for 20 minutes, centrifuged and resuspended in cold buffer at 1 × 10 6 per ml.
Histology and Immunohistochemical Characterization
Immunohistochemistry was performed by an indirect immunoperoxidase procedure for localization of select proteins (Monga et al., 2001) . Primary antibody was against Sca-1 (BD Biosciences; San Jose, CA). The secondary antibody was from Vector Laboratories (Burlingame, CA) and the signal was detected using the ABC Elite and DAB kits (Vector Laboratories, Burlingame, CA). DAB staining was toned with DAB Enhancer (Vector Laboratories) and counterstained with hemotoxylin. Slides were blocked with Protein Blocking Agent (Thermo Electron Solutions; Pittsburgh, PA). For negative control, sections were incubated with isotype control antibodies. All stained slides were viewed on the Nikon Microphot-FXA microscope. It is equipped with an Optronics DEI 750 3-chip CCD camera and a Q Imaging Micropublisher CCD camera for digital image acquisition. Images were captured on an Apple Power Macintosh G3 computer utilizing Q Imaging software and saved using Adobe Photoshop CS2 software.
RT-PCR
Polymerase chain reaction (PCR) analysis was performed on total RNA extracted from isolated Sca-1 positive and negative cells. A total of 2g of total RNA was used as a template to create complementary DNA as per the manufacturer's instructions for the Retroscript kit from (Ambion; Austin, TX). The sequences for selected primers are listed in Supplemental Data Table 1 . The generated complementary DNA was then subjected to a denaturing temperature of 95˚C for 2 minutes, followed by further denaturation at 95˚C for 1 min, annealing temperatures of 55˚C -70˚C for 45 seconds, and extension for 60 seconds at 72˚C for 50 cycles, followed by a final extension at 72˚C for 5 minutes. 
Western Blot Analysis
Cells were lysed in buffer containing 50mM Tris, 150mM NaCl, 1% Nonidet P40 (Roche; Indianapolis, IN), 0.5% deoxycholate, 1mL protease inhibitor cocktail for every 100 mL (5 μg/mL aprotinin, leupeptin, pepstatin, and soybean trypsin inhibitor), and 1mL phosphatase inhibitor for every 100 mL. Lysates were clarified by centrifugation at 14,000 g × 2 min and stored at -20˚C. Protein concentrations were determined by BioRad protein assay. Total cellular proteins (50 μg/lane) were dissolved by SDS-PAGE, transferred to nitrocellulose membrane incubated with blocking buffer (5% nonfat dry milk in 1× Tris Buffered Saline with 0.05% Tween 20, pH 7.5), and probed with primary antibodies. After incubation with secondary antibodies, peroxidase activity was detected by enhanced chemiluminescence. Densitometric signals from Western blots were analyzed with NIH-ImageJ software (http://rsb.info.nih.gov/ij/) [31] . Protein levels were calculated in arbitrary units (AU) normalized with β-actin protein levels.
Insulin Assay
Insulin secretion was measured using an enzyme linked immunosorbent assay (ELISA). Cells were cultured in either a high or low glucose environment (5 mM and 25 mM respectively) for either a 4 or 48 hour duration. Supernatant was collected from culture dishes and placed at -20˚C storage. The samples were allowed only 1 freeze-thaw before analysis. The samples were analyzed according to the manufacturer's protocol (Alpco Diagnostics, Salem, NH) by the UNC Center for Gastrointestinal Biology and Disease (CGIBD) Immunotechnology core facility funded by NIH grant# P30-DK34987and the insulin concentrations calculated using standard curves generated from each assay.
Cell Proliferation Assay
Cell growth and proliferation were measured using the CyQUANT ® NF Cell Proliferation Assay Kit (Invitrogen Molecular Probes ™ ; Eugene, OR) which measures DNA content. Cells were allowed to proliferate in 96 well culture dishes for set time points of 0,1,4,7,14, and 21 days. On test day growth medium was removed and 50 µl of 1× binding dye from kit added. Cells were further incubated for 30 minutes and then assayed on a BioTek Microplate reader at emission wavelengths of 485 and 530 nm. Absorbance values obtained were then correlated to cell numbers using a standard curve. Standard curve was created previously with a rapidly proliferating cell line. pulations including hematopoietic stem cells, endothelial progenitor cells, adipose stem cells and hepatic stem cells [32] [33] [34] [35] . Pancreatic tissue isolated from newborn and adult mice, (12 days and 6 weeks old, respectively) was evaluated for the presence of Sca-1 + cells. In newborn mice the Sca-1 + cells are localized in the periductal region ( Figure   1(a) ). In adult mice Sca-1 + cells are located in a periductal and peri-islet distribution (Figure 1(b) ) with a noted absence of Sca-1 + cells within the islet matrix.
Openly accessible at
Pancreatic tissue was subsequently disbursed into a cellular suspension using a combination of mechanical and enzymatic separation techniques followed by enrichment for the Sca- Figure S1 -Supplemental Data).
Cellular Proliferation and Characterization
After isolation, the Sca-PPC were placed on tissue culture dishes using a modification of Ta's media conditions [36] . Small colonies of tightly packed cells with large nuclei are seen on the dishes within the first three days of culture (Figure 2a) . These colonies rapidly expand in culture forming large colonies. As these cells proliferate they morphologically change with an increase in cytoplasm to nucleus ratio (Figure 2b) . Assessing the rate of cellular proliferation using a mitochondrial assay demonstrates an initial slow proliferation rate of the Sca-PPC during the first week of culture followed by an acceleration over the subsequent 14 days in culture (Figure 2c) . Due to the periductal location of the Sca-PPC in the pancreatic parenchyma we analyzed the tissue for CK19 expression, a marker associated with ductal cells (e.g. bile ducts, pancreatic ducts, etc.). (Supplemental Figure S2) Immunohistochemistry of the pancreatic tissue demonstrates similar staining patterns for CK19 and Sca-1. We subsequently evaluated the proliferating Sca-PPC for CK19 expression. Figure 3 demonstrates CK19 expression on a day 7 colony of proliferating Sca-PPC. During the in vitro culture period, the Sca-PPC were analyzed for persistence of Sca-1 expression. Figure 4 is a day 3 colony demonstrating persistent Sca-expression on the cells. The nuclei of these cells are counterstained with DAPI.
Transcription Factors and Differentiation
Transcription factor expression associated with pancreatic development and/or mature pancreatic cells was evaluated in the Sca-PPC population. We selected defined time points to evaluate cellular differentiation: immediately after isolation (P0) and in culture after the cells had been passaged (P2 and P4). Murine islets were used as a control for these experiments. The Sca-PPC demonstrates expression of Hnf6 at isolation and at later passage, P4. These cells also expressed Pax6, Nkx2.2, Pdx-1, Ptf1-α, Ngn3, NeuroD, nestin, CK19, Insulin 1 and 2 but did not express Glut 2. Figure 5 is a representative set of images from these experiments. Experiments were performed a minimum of three times to confirm the presence or absence of a transcription factor.
Based on the PCR results we assessed Sca-PPC differentiation by comparing markers associated with the endocrine component of the islet and the acinar fraction of the pancreas. Western blot analyses demonstrate de novo low expression levels of glucagon and Ngn3 which persist during cell passage. Insulin receptor-α expression is higher at all three time points in culture, but there are no statistically significant differences in this experiment ( Figure  6 ). The Sca-PPC also demonstrates de novo expression of amylase with persistent expression during cell culture.
Pdx-1 is selectively expressed in β-cells and is essential for maintenance of phenotype in adult β-cells [37] . Based on the finding of Pdx-1 by PCR ( Figure 5) we performed immunofluorescense analysis of the Sca-PPC colonies to assess cellular expression. Figure 7 demonstrates strong Pdx-1 expression on the majority of colony-forming Sca-PPC. 
Insulin Production of PPC
Experiments were established to analyze Sca-PPC insulin production looking at both sustained production and rapid response to environmental changes in glucose concentration. The Sca-PPCs demonstrate a basal production of insulin using either low or high glucose concentrations (P0 cells) while the cells that have been passaged twice (P2) demonstrate an increase in insulin secretion at both low and high glucose concentrations (Figure  8(a) ). In the later passage (P4), insulin production is similar to the pattern demonstrated when the cells are initially isolated. These assays are based on a 48 hour collection sample and potentially mask rapid changes in insulin secretion. We established a rapid response assay with the Sca-PPC at both low and high glucose concentrations and compared them with freshly isolated islets. Samples were assessed immediately after the media change (30 minutes) and several times over a four hour period. This experiment demonstrates persistent basal insulin production by the Sca-PPC without acute responsiveness to 8(b) ). Sca-PPC insulin production is distinctly different from islets cultured in high glucose concentration media. Comparatively the Sca-PPC have a higher production of insulin in low glucose concentration media experiments compared with islets at the same time points, 30 and 60 minutes respectively (Figure 8b ).
DISCUSSION
Diabetes is currently the seventh leading cause of death, the leading cause of kidney failure, lower limb amputations, and blindness, as well as a major contributor to + PPCs. PCR analysis shows that PPCs differentiate toward multiple lineages of pancreatic fate and not toward simply endocrine β-cell fate. Cells were assayed at passage 0, 2, and 4 for the listed pancreatic transcription factors. Ck19 was also analyzed since its expression was seen in staining in vitro (refer to Figure 3) . heart disease and stroke in the US [38] . Current treatment options for Type 1 diabetics do not offer physiologically-responsive strict control of blood sugar levels to prevent the development of the previously mentioned complications. Islet cell transplant is a clinically proven method to treat Type I diabetes but it is challenged by severe limitations in donor availability, poor long term success rate, and the requirement for immunosuppression. For these reasons an alternative cell source that could provide glucose responsiveness offers a potential cure to the approximately 2 million newly diagnosed T1D patients each year in the US and the T2D insulin dependent patients [38] .
Ongoing debate in the field of stem cell biology questions the existence of a progenitor cell in adult pancreatic tissue. Initial studies have shown that new β-cells arise as a result of division of pre-existing β-cells throughout life and after pancreas injury, thus casting doubt on the idea of stem cell contributions [9, 10, 39, 40] . This contrasts with others who have shown that a stem cell does exist in the pancreas. Seaberg et al. isolated pancreatic precursors from adult mouse pancreas and demonstrated that the cells are positive for many β-cell markers and capable of releasing insulin in response to glucose stimulation [28] . However, the amount of insulin produced by these cells was much lower than what is produced by a naturally occurring islet-derived β-cell. It has also been shown that endocrine precursors can be derived from surgically resected portions of human pancreas and that islets themselves contain a population of mesenchymal stem cells [41, 42] . Recently published data bolsters the idea of a precursor cell in pancreas citing the existence of insulin positive multipotent stem cells that give rise to pancreatic and neural lineages and that ameliorate diabetes in animal models [43] .
Novel cell surface antibodies are being developed that allow the selective isolation of individual cell populations, (e.g. exocrine cells) providing a useful tool to study adult derived progenitors [44] . Our current study demonstrates the presence of a tissue derived progenitor cell from murine pancreas that is highly proliferative and able to be purified using a select cell surface marker, Sca-1
+ . Other reports demonstrate Sca-1 expression in progenitor cells of the kidney, liver, cardiac and skeletal muscle, and mammary tissue but to our knowledge this is the first report of a Sca-1 + progenitor cell residing in murine pancreas [34, [45] [46] [47] [48] .
CK19 is another marker found on the Sca-PPCs during in vivo and in vitro assessment. CK19 is a ductal marker and its expression in murine pancreas is found to overlap with ductal areas positive for Sca-1. In early cell culture experiments all of the Sca-PPC colonies are positive for CK19. This expression of CK19 is important in translating our research to other species. Sca-1 is an antigen that is specific to murine tissues thus an alternative marker is needed when we analyze human tissue. Several groups have reported the possibility of multipotent stem cells associated with ductal areas and the biliary ducts that traverse the pancreas, [16, 49, 50] . The presence of CK19 in our Sca-PPCs may indicate overlap with other isolated precursor cells and offer an opportunity for exploration of new antigens of interest.
Analysis of cultured Sca-PPCs demonstrates variability in the expression of differentiation markers. The cells initially express many of the developmental markers associated with pancreatic and endocrine progenitor cells, including Hnf-6, Ptf1α, PDX-1, Pax6, Nkx2.2, Ngn3, NeuroD, and Nestin. Variability in transcription factor expression is demonstrated throughout the periods of culture that were studied. After initially expressing multiple endocrine developmental markers the Sca-PPCs lose expression of Hnf6 and Pax6 while maintaining expression of Nkx2.2, Ngn3 and Neuro D. Cells also express differ-entiated cell markers including Insulin1, Insulin2, Glut2, and CK19. These markers are initially present but by the time the cells have undergone multiple passages the cells lose expression of both Insulin 1 and 2. A possible explanation for the variability of expression could relate to cell-cell interactions in the in vitro cellular environment and the impact on the cells, as cells cultured on a rigid surface have been previously associated with cellular differentiation [51, 52] . Maintaining the cells in a 2-D environment thereby limits their ability to develop normally and forces the cells to differentiate based on constraints of the culture vessel as well as causing cell death due to limited space.
PDX-1 is a transcription factor that is present during early development of the pancreas and is essential for the differentiation process into mature β-cells. For this reason its presence would theoretically be essential in any cell population which has the potential of becoming a functional islet-like cell. Sca-PPCs express PDX-1 throughout culture at the transcriptional level although in vitro analysis demonstrates its expression in the cells' cytoplasm. This is distinct from the typical nuclear location of PDX-1. This cytoplasmic localization in the PPCs suggests signal transcription but not translation of the protein into an active form. This observation has been demonstrated by other investigators where PDX-1 is found in an inactive form in the cytoplasm of the islet when glucose concentrations are low. PDX-1 is then activated by phosphorylation when glucose concentrations increase and the active form is translocated to the cell nucleus [53] [54] [55] [56] .
Protein analysis of the Sca-PPC population shows that cells express the developmental markers Ngn3 and PDX-1 throughout the analyzed periods of culture. The cells also express mature endocrine proteins glucagon and Insulin Receptor α. Likewise, the mature exocrine cell marker amylase is expressed throughout the in vitro culture periods. The expression levels of each protein vary throughout the experiment showing the cells' ability for endocrine and exocrine functions.
Sca-PPCs have the functional ability to produce large in vitro amounts of insulin. This is a distinct finding compared to published studies where insulin secretion is very limited in progenitor cell populations. Sca-PPCs from adult mice produce a steady state of insulin across passages and over a 2 day period of culture yet the release is independent of changes in glucose concentration. Neonatal mice are capable of responding to glucose concentration changes at passage 2, but do not maintain this ability in extended culture. In acute phase experiments there is no increase in insulin secretion from the Sca-PPCs in high glucose conditions over a four hour period. In fact, cells exposed to low glucose conditions released more insulin than their high glucose counterparts. This was in stark contrast to islets which show a drastic increase in insulin secretion at high concentrations and only a minor increase in low glucose conditions. Finding a way to direct the secretion of insulin in response to glucose stimulation in the Sca-PPC's may show that they have potential as a stem cell source capable of treating diabetes.
This study demonstrates the presence of a Sca-1 + progenitor cell subset in the murine pancreas. The expression of CK19 offers a potential complementary marker for selection of a correlating population in human pancreatic tissue. This co-expression of ductal markers may also offer insight to the origin of these progenitor cells. Based upon the common embryologic development of pancreas and liver from the foregut endoderm the complex ductal networks of both organs likely share a common origin. This is corroborated by the fact that our lab previously identified a Sca-1 + cell residing in adult murine liver [34] . Regulation of the proliferative and differentiation features of this cell population will be critical as we continue to investigate alternative strategies for glucose regulation in our diabetic population. 
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